Tuberculosis and Respiratory Diseases

The Korean Academy of Tuberculosis and Respiratory Diseases (대한결핵및호흡기학회)
권호 표지
DOI QR코드

DOI QR Code

Measurement of Fractional Exhaled Nitric Oxide in Stable Bronchiectasis

  • Cho, Young-Jae (Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine) ;
  • Lim, Hyo-Jeong (Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine) ;
  • Park, Jong Sun (Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine) ;
  • Lee, Jae Ho (Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine) ;
  • Lee, Choon-Taek (Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine) ;
  • Yoon, Ho Il (Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine)
  • Received : 2012.12.19
  • Accepted : 2013.01.11
  • Published : 2013.01.30
Download PDF
⟨ Previous Next ⟩

Abstract

Background: Fractional exhaled nitric oxide (FeNO) can be measured easily, rapidly, and noninvasively for the assessment of airway inflammation, particularly mediated by eosinophil, such as asthma. In bronchiectasis (BE), the pathogenesis has been known as chronic airway inflammation and infection with abnormal airway dilatation; however, there are little studies to evaluate the role of FeNO in BE. Methods: From March 2010 to February 2012, 47 patients with BE, diagnosed by high resolution computed tomography (HRCT), performed FeNO, compared with asthma and chronic obstructive pulmonary disease (COPD). All patients carried out a complete blood count including eosinophil count, chemistry, sputum examination, and spirometry, if indicated. A retrospective analysis was performed to elucidate the clinical role of FeNO in BE patients. Results: The mean FeNO levels in patients with BE was $18.8{\pm}1.5$ part per billion (ppb), compared to $48.0{\pm}6.4$ and $31.0{\pm}4.3$ in those with asthma and COPD, respectively (p<0.001). The FeNO levels tended to increase along with the disease severity scores by HRCT; however, it was statistically not significant. FeNO in BE with a co-infection of nontuberculous mycobacteria was the lowest at $17.0{\pm}3.5$ ppb among the study population. Conclusion: FeNO in BE was lower than other chronic inflammatory airway diseases, particularly compared with asthma. For clinical application of FeNO in BE, more large-scaled, prospective studies should be considered.

Keywords

References

  1. Nathan C, Xie QW. Regulation of biosynthesis of nitric oxide. J Biol Chem 1994;269:13725-8.
  2. Kim SH, Yoon HJ. Use of the exhaled nitric oxide for management of asthma and respiratory diseases. Korean J Med 2008;74:579-86.
  3. Barnes PJ, Dweik RA, Gelb AF, Gibson PG, George SC, Grasemann H, et al. Exhaled nitric oxide in pulmonary diseases: a comprehensive review. Chest 2010;138:682-92 https://doi.org/10.1378/chest.09-2090
  4. Kharitonov SA, Wells AU, O'Connor BJ, Cole PJ, Hansell DM, Logan-Sinclair RB, et al. Elevated levels of exhaled nitric oxide in bronchiectasis. Am J Respir Crit Care Med 1995;151:1889-93. https://doi.org/10.1164/ajrccm.151.6.7767536
  5. Wang CH, Liu CY, Lin HC, Yu CT, Chung KF, Kuo HP. Increased exhaled nitric oxide in active pulmonary tuberculosis due to inducible NO synthase upregulation in alveolar macrophages. Eur Respir J 1998;11:809-15. https://doi.org/10.1183/09031936.98.11040809
  6. Dweik RA, Boggs PB, Erzurum SC, Irvin CG, Leigh MW, Lundberg JO, et al. An official ATS clinical practice guideline: interpretation of exhaled nitric oxide levels (FENO) for clinical applications. Am J Respir Crit Care Med 2011;184:602-15. https://doi.org/10.1164/rccm.9120-11ST
  7. Kim C, Kim DG. Bronchiectasis. Tuberc Respir Dis 2012;73:249-57. https://doi.org/10.4046/trd.2012.73.5.249
  8. Kharitonov SA, Barnes PJ. Exhaled biomarkers. Chest 2006;130:1541-6. https://doi.org/10.1378/chest.130.5.1541
  9. Tsang KW, Leung R, Fung PC, Chan SL, Tipoe GL, Ooi GC, et al. Exhaled and sputum nitric oxide in bronchiectasis: correlation with clinical parameters. Chest 2002;121:88-94. https://doi.org/10.1378/chest.121.1.88
  10. Ho LP, Innes JA, Greening AP. Exhaled nitric oxide is not elevated in the inflammatory airways diseases of cystic fibrosis and bronchiectasis. Eur Respir J 1998;12: 1290-4. https://doi.org/10.1183/09031936.98.12061290
  11. Narang I, Ersu R, Wilson NM, Bush A. Nitric oxide in chronic airway inflammation in children: diagnostic use and pathophysiological significance. Thorax 2002;57: 586-9. https://doi.org/10.1136/thorax.57.7.586
  12. Shoemark A, Devaraj A, Meister M, Ozerovitch L, Hansell DM, Wilson R. Elevated peripheral airway nitric oxide in bronchiectasis reflects disease severity. Respir Med 2011;105:885-91. https://doi.org/10.1016/j.rmed.2011.01.015
  13. Van Beek SC, Nhung NV, Sy DN, Sterk PJ, Tiemersma EW, Cobelens FG. Measurement of exhaled nitric oxide as a potential screening tool for pulmonary tuberculosis. Int J Tuberc Lung Dis 2011;15:185-92.
  14. Ryoo SW, Shin S, Shim MS, Park YS, Lew WJ, Park SN, et al. Spread of nontuberculous mycobacteria from 1993 to 2006 in Koreans. J Clin Lab Anal 2008;22: 415-20. https://doi.org/10.1002/jcla.20278
  15. Oikonomou A, Tsanakas J, Hatziagorou E, Kirvassilis F, Efremidis S, Prassopoulos P. High resolution computed tomography of the chest in cystic fibrosis (CF): is simplification of scoring systems feasible? Eur Radiol 2008; 18:538-47. https://doi.org/10.1007/s00330-007-0810-z
  16. Idh J, Westman A, Elias D, Moges F, Getachew A, Gelaw A, et al. Nitric oxide production in the exhaled air of patients with pulmonary tuberculosis in relation to HIV co-infection. BMC Infect Dis 2008;8:146. https://doi.org/10.1186/1471-2334-8-146
  17. Robroeks CM, Roozeboom MH, de Jong PA, Tiddens HA, Jobsis Q, Hendriks HJ, et al. Structural lung changes, lung function, and non-invasive inflammatory markers in cystic fibrosis. Pediatr Allergy Immunol 2010;21:493-500. https://doi.org/10.1111/j.1399-3038.2009.00872.x

Cited by

  1. Significance of fractional exhaled nitric oxide in chronic eosinophilic pneumonia: a retrospective cohort study vol.14, pp.None, 2013, https://doi.org/10.1186/1471-2466-14-81
  2. Factors associated with bronchiectasis in patients with uncontrolled asthma; the NOPES score: a study in 398 patients vol.19, pp.None, 2018, https://doi.org/10.1186/s12931-018-0746-7
  3. Clinical features associated with a doctor-diagnosis of bronchiectasis in the Severe Asthma Network in Italy (SANI) registry vol.15, pp.3, 2013, https://doi.org/10.1080/17476348.2021.1840983